Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Experts on Generic Pharmaceuticals: Pharmacists

Council Members in this Study Group: 107

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Leo Pavliv, RPh, MBA

VP Operations
CUMBERLAND PHARMACEUTICALS, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Leo Pavliv, RPh, MBA, is Vice President Operations at Cumberland Pharmaceuticals in Tennessee. His job responsibilities include directing overall drug development activities for numerous products, regulatory affairs, product development, clinical and non-clinical development, manufacturing, and quality...

Bruce Goldberg

President
Pharmacy Benefit Advisors
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Bruce Goldberg is the President of Pharmacy Express Services and Pharmacy Benefit Advisors, both based in Omaha, Nebraska. He is a pharmacist and has experience in managed care with PBM contracting and general pharmacy network management. He developed a program which allows generic and therapeuticsubstitution...

1 recent news post(s)
Dea Belazi, PharmD, MPH, PAHM, Pharmacy Consultant, Dea Belazi, PharmD, MPH, PAHMDea Belazi, PharmD, MPH, PAHM

Pharmacy Consultant
Dea Belazi, PharmD, MPH, PAHM
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Dea Belazi, PharmD, MPH, PAHM, is currently a Consultant working with health plans and pharmaceutical companies. Dr. Belazi is also a Consulting Practice Leader for Wolters Kluwer Health- Managed Care Group. Previously, he was the Senior Director of Pharmacy Services for Independence Blue Cross, alarge...

4 recent news post(s)
2 recent event(s)
Steven Miller, MS, DPH, President, Steven Miller, MS, DPHSteven Miller, MS, DPH

President
Steven Miller, MS, DPH
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Steven Miller, MSPharm, DPH, is the President and Chief Executive Officer of SJM Enterprises, a multi-faceted consumer-response organization, specializing in workers compensation, medication therapy management, and managed care pharmaceutical reimbursement issues, where he is working since February...

1 recent news post(s)
David Zimmerman, PharmD

President/Owner
Doctors of Pharmacy, Inc.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

David Zimmerman, PharmD, FASCP, is the President and an Independent Consultant of Doctors of Pharmacy. Dr. Zimmerman formerly served as the Director of Clinical Affairs at Employee Health Insurance Management, a pharmacy benefit manager. He has over 30 years of experience, specializing in pharmacyservices...

9 recent news post(s)
Tim Gallagher, RPh, Executive Vice President of Pharmacy Operations , ASTRUP DRUG, INC.Tim Gallagher, RPh

Executive Vice President of Pharmacy Operations
ASTRUP DRUG, INC.
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Tim Gallagher, RPh, is the Executive Vice President of Pharmacy Operations at Astrup Drug in Minnesota, since 1999. Mr. Gallagher manages all aspects of pharmacy operations for the company. He has been a practicing pharmacist for over 25 years in both the chain and independent community pharmacy setting...

8 recent news post(s)
Aemad Aslam, MBA

President
MindPharma
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Aemad Aslam, BPharm, MBA, RPh, is the President of MindPharma, a pharmacy and retail strategy consulting group. Most recently, he has consulted with a PBM, Prime Therapeutics, in Texas, a subsidiary of Blue Cross Blue Shield. He also has served as an Executive Team Leader for Pharmacy at the Target...

7 recent news post(s)
Robert Warnock, DPh

Vice President of Pharmacy Services
Golden Clinical Services
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Robert Warnock, DPh, CGP, FASCP is Vice President of Pharmacy Services at Golden Clinical Services in Fort Smith, AR, and is an Adjunct Assistant Professor of Geriatrics at Mercer University Southern School of Pharmacy in Atlanta, Georgia. He was previously Regional Clinical Director of the Southeastern...

4 recent news post(s)

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Thriving in a time of adversity - Sun Pharma pounces on shortage by getting approval on Oxycodone

April 13, 2009

Aemad Aslam, MBA, President, MindPharma

Sun Pharma gets USFDA's nod to market painkillers | www.hindu.com

Sun Pharma can greatly benefit from the nationwide shortage of Oxycodone Immediate Release Tablet, by getting approval from the FDA on their own generic. With recent recalls from different manufacturers, and the shortage of a comparable product Morphine Sulphate, the FDA currently estimates that return...

Aurobindo Pharma's Escitalopram will be a big mover ... when it comes out in 2011

March 5, 2009

Aemad Aslam, MBA, President, MindPharma

Aurobindo Pharma receives tentative approval for Escitalopram | www.indiainfoline.com

Forest's Lexapro commands a $2.5+ billion USD market share, just in the US.  Due to such a high volume of the brand product, Aurobindo's tentative approval on Lexapro's generic Escitalopram will be a great opportunity - primarily if they can procure a 6 month period of exclusivity from the FDA. ...

Teva's Generic Imitrex commands market of Sumatriptan

February 26, 2009

Aemad Aslam, MBA, President, MindPharma

Teva Announces Approval and Launch of Generic Imitrex(R) Tablets | www.pipelinereview.com

With the 180 day exclusivity, Teva is already commanding the market of the generic Imitrex - Sumatriptan oral tablets.  Teva maintains an AB rating of the generic that will render most insurance companies to push brand name Imitrex by GlaxoSmithKline to a non-formulary tier, skyrocketing the...

Acquisitions of Indian Pharma on the extended horizon by Brand name pharma

February 23, 2009

Aemad Aslam, MBA, President, MindPharma

Pharma cos on lookout for Indian drug firms | economictimes.indiatimes.com

Acquisitions of various Indian generic pharmaceuticals is likely on the horizon for brand name manufacturers.  However, this is not an immediate concern.  I would see more consolidations in the US and other Western markets first. 

Sun Pharma - much stronger with acquisitions including Taro

February 17, 2009

Aemad Aslam, MBA, President, MindPharma

As valuations dip, Sun Pharma is in M&A mode | economictimes.indiatimes.com

Sun Pharma is attempting to gain market share in the world largest market - the US market.  Sun Pharma is clearly expanding it product base with venturing into topical (dermatological) and pediatric segments, and with vertical integration as with raw materials suppliers.  Sequentially, Iwould...

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Pharmacy or Drug Store, Chain
  • Pharmacy or Drug Store, Independent/Local
  • Academic Medical Center/Hospital or Clinic
  • Consultancy, Pharma-Focused
  • Facility, Academic Medical Center
  • Office Based Private Practice or Clinic
  • Pharmaceuticals Manufacturer

Members in this Study Group often have these job titles:

  • Director
  • Pharmacist - RPh/PharmD
  • Owner
  • Manager
  • President
  • Operations Executive
  • Consultant
  • Principal

Related Study Groups

Study Group Name No. Members
Generic Drug Economic Experts 767
Pharmacists (US) 2079
Formulary Design Experts 252
Economic Experts on Formulary Designs (US) 51
Economic Experts on Managed Care 716
Medicare Experts 495
Zocor Pricing Experts (US) 38